Exploring dynamics and strategies of niche protection

This paper focuses on the processes and strategies of advocates and opponents in creating, maintaining and/or contesting the protective spaces in which ‘urgently needed’ but ‘risky’ pharmaceutical innovations are managed. Drawing on transition literature and recent work on niche protection, this paper adds to the conceptualisation and empirical grounding of niche protection by studying the dynamics of protection, in particular the different phases of niche development. Moreover, the links between niche protection processes and protection strategies pursued by niche players are explored. Dynamics of niche protection are explored in two case studies: the monitoring of treatments for HIV and of a vaccination against pandemic influenza. We conclude that niche protection depends on interactions between network building, empowerment activities and the construction of a positive niche narrative vis-a-vis anti-narratives raised by actors outside the niche. Furthermore, the nature of learning within a niche and the niche's robustness are determined by whether the strategies are predominantly accommodating or restrictive.

[1]  Frank W. Geels,et al.  Comment on 'Techno therapy or nurtured niches?' by Hommels et al. Res. Policy 36(7) (2007) , 2007 .

[2]  Arie Rip,et al.  Introduction of New Technology; Making Use of Recent Insights from Sociology and Economics of Technology , 1995 .

[3]  K. Eisenhardt.  Building theories from case study research , 1989, STUDI ORGANIZZATIVI.

[4]  Johan Schot,et al.  Strategies for shifting technological systems : the case of the automobile system , 1994 .

[5]  Rob Raven,et al.  What is protective space? Reconsidering niches in transitions to sustainability , 2012 .

[6]  Johan Schot,et al.  Experimenting for Sustainable Transport: The Approach of Strategic Niche Management , 2002 .

[7]  Mads Borup,et al.  The sociology of expectations in science and technology , 2006, Technol. Anal. Strateg. Manag..

[8]  M. Zambon,et al.  Confronting the avian influenza threat: vaccine development for a potential pandemic , 2004, The Lancet Infectious Diseases.

[9]  L. J. D. Berg,et al.  Adverse Drug Reaction Reporting by Patients in the Netherlands Three Years of Experience , 2008, Drug safety.

[10]  E. Hippel,et al.  Lead users: a source of novel product concepts , 1986 .

[11]  Frank W. Geels,et al.  Strategic niche management and sustainable innovation journeys: theory, findings, research agenda, and policy , 2008, Technol. Anal. Strateg. Manag..

[12]  Anique Hommels,et al.  Techno therapy or nurtured niches? Technology studies and the evaluation of radical innovations , 2007 .

[13]  Adrian Smith,et al.  Translating Sustainabilities between Green Niches and Socio-Technical Regimes , 2007, Technol. Anal. Strateg. Manag..

[14]  R. Raven.  Towards alternative trajectories? Reconfigurations in the Dutch electricity regime , 2006 .

[15]  Thomas J. Misa,et al.  Managing technology in society: the approach of constructive technology assessment , 1997 .

[16]  Ellen Moors,et al.  Exploring emerging technologies using metaphors--a study of orphan drugs and pharmacogenomics. , 2008, Social science & medicine.

[17]  J. March.  Exploration and exploitation in organizational learning , 1991, STUDI ORGANIZZATIVI.

[18]  Rpjm Rob Raven,et al.  Biofuel developments in Sweden and the Netherlands : protection and socio-technical change in a long-term perspective , 2009 .

[19]  R. Raven.  Strategic Niche Management for Biomass , 2008 .

[20]  R. Kemp,et al.  Evolutionary approaches for sustainable innovation policies: From niche to paradigm? , 2009 .

[21]  Marshall Scott Poole,et al.  Methods for Studying Innovation Development in the Minnesota Innovation Research Program , 1990 .

[22]  Adrian Smith,et al.  Spaces for sustainable innovation: Solar photovoltaic electricity in the UK , 2014 .

[23]  Alasdair Breckenridge,et al.  Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma , 2008, Nature Reviews Drug Discovery.

[24]  J. Schot,et al.  Regime shifts to sustainability through processes of niche formation : the approach of strategic niche management , 1998 .

[25]  Marian Stuiver,et al.  Niches and networks: Explaining network evolution through niche formation processes , 2013 .

[26]  S. Epstein.  Activism, Drug Regulation, and the Politics of Therapeutic Evaluation in the AIDS Era: A Case Study of ddC and the `Surrogate Markers' Debate , 1997, Social studies of science.

[27]  F. Geels,et al.  Typology of sociotechnical transition pathways , 2007 .

[28]  John Grin,et al.  Implermentation as communicative action. An interpretative understanding of interactions between policy actors and target groups , 1996 .

[29]  E. V. van Puijenbroek,et al.  Monitoring adverse events of the vaccination campaign against influenza A (H1N1) in the Netherlands. , 2010, Drug safety.